The effect of merthiolate on the inmunogenicity of foot-and-mouth disease virus antigens
dc.contributor.author | Abaracón, Daniel | |
dc.date.accessioned | 2018 | |
dc.date.available | 2018 | |
dc.date.issued | 1977 | |
dc.identifier.citation | Abaracón D. The effect of merthiolate on the inmunogenicity of foot-and-mouth disease virus antigens. Bol Cent Panam Fiebre Aftosa. 1977; 26: 47-48. | en_US |
dc.identifier.issn | 0009-0131 | |
dc.identifier.uri | https://iris.paho.org/handle/10665.2/49617 | |
dc.description.abstract | Merthiolate is commonly used as a preservative in commercial inactivated foot-and-mouth disease (FMD) vaccines. However, experiments with inactivated poliomyelitis vaccines have shown that degradation products of merthiolate can affect the virus antigen during storage of the vaccine (1). The effect of merthiolate can be neutralized by treatment with EDTA (trisodium salt of ethylene diamine tetra-acetic acid). Precipitation reactions in agar gel with FMD virus also show deleterious effects of merthiolate (2). | en_US |
dc.language.iso | en | en_US |
dc.publisher | PAHO | en_US |
dc.relation.ispartofseries | Bol Cent Panam Fiebre Aftosa;26 | |
dc.subject | Foot-and-Mouth Disease | en_US |
dc.subject | Foot-and-Mouth Disease Virus | en_US |
dc.subject | Antigens | en_US |
dc.title | The effect of merthiolate on the inmunogenicity of foot-and-mouth disease virus antigens | en_US |
dc.type | Publications | en_US |
dc.rights.holder | Pan American Health Organization | en_US |
dc.contributor.corporatename | Pan American Health Organization | en_US |
paho.isfeatured | 0 | en_US |
paho.publisher.country | Brazil | en_US |
paho.publisher.city | Rio de Janeiro | en_US |
paho.source.centercode | BR680.1 | en_US |
paho.contributor.department | Centro Panamericano de Fiebre Aftosa y Salud Pública Veterinaria (PANAFTOSA) | |
paho.iswhotranslation | No | en_US |